This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Faculty of Philosophy, University PIM Banja Luka , Banja Luka , Bosnia and Herzegovina
Scientific interest in psychedelic drugs has increased exponentially over the past decade. Just in the last few years, small controlled clinical trials examining the potential therapeutic utility of psilocybin-assisted therapy in patients suffering from anxiety, depression, and substance abuse have reported extremely positive outcomes. Hallucinogen has perhaps been most widely used in scientific literature and is the legal designation used to classify these substances in many countries. Unfortunately, it also is a misnomer because these compounds rarely evoke true hallucinations and do not normally impair reality testing. Furthermore, a wide range of psychoactive substances, including cannabinoids, dissociative anesthetics, anticholinergics, and entactogens such as MDMA, can produce “hallucinogenic” effects. Hence, LSD-like drugs are often referred to as classical hallucinogens or serotonergic hallucinogens in order to distinguish them from other drug classes.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
